We are PZM21 CAS:1997387-43-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Market News:Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. 5-Hydroxy-3-oxo-5-p-tolyl-pentanoic acid ethyl ester manufacturer.CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. N1-((1S,2R)-1-benzyl-3-{[3-(difluoromethoxy)benzyl]amino}-2-hydroxypropyl)-N3,N3-dipropylisophthalamide supplier.AstraZeneca acquired global rights to anifrolumab through an exclusive license and collaboration agreement with Medarex, Inc. in 2004. Medarex was acquired by Bristol-Myers Squibb in 2009. N-[1,3-dimethyl-2-(1-methyl-allyloxy)-2λ5-[1,3,2]diazaphospholidin-2-ylidene]-4-methyl-benzenesulfonamide producer.
Product Name | |
---|---|
(E)-4-(Dimethylamino)But-2-Enoic Acid Hydrochloride | View Details |
9-(4-bromonaphthalen-1-yl)-10-phenylanthracene | View Details |
4-benzyl-2-hydroxymorpholin-3-one | View Details |